Regeneron Pharmaceuticals Inc (NASDAQ:REGN) announced an agreement with theBiomedical Advanced Research and Development Authority (BARDA) of the U.S.
Regeneron Pharmaceuticals Inc (NASDAQ:REGN) released its second-quarter earnings results today, with U.S.
Regeneron Pharmaceuticals Inc (NASDAQ:REGN) announced financial results for the second quarter of 2016 and provided a business update. “In the first half of …
Regeneron Pharmaceuticals Inc (NASDAQ:REGN) and Adicet Bio, Inc.announced today a collaboration and licensing agreement to develop next-generation engineered immune cell therapeutics.
Regeneron Pharmaceuticals Inc (NASDAQ:REGN) and Sanofi announced that the Ministry of Health, Labor and Welfare in Japan has granted marketing and manufacturing authorization for …
Regeneron Pharmaceuticals Inc (NASDAQ:REGN) announced financial results for the first quarter of 2016 and provided a business update. “The year is off to …
It’s an exciting week ahead for pharmaceutical companies Relypsa Inc (NASDAQ:RLYP), GW Pharmaceuticals PLC-ADR (NASDAQ:GWPH), Regeneron Pharmaceuticals Inc (NASDAQ:REGN), and Exelixis, Inc. (NASDAQ:EXEL), as …
Yesterday, Jennifer asked is Valeant Pharmaceuticals the proverbial canary in the coal mine for the pharma industry? She came to the conclusion that …
Regeneron Pharmaceuticals Inc (NASDAQ:REGN) announced financial results for the fourth quarter and full year 2015 and provided an update on development programs. “Regeneron had …
Regeneron Pharmaceuticals Inc (NASDAQ:REGN) and Sanofi announced that the U.S.
